Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: A novel approach with fluorodeoxyglucose-PET
dc.contributor.author | Berkowitz, A. | |
dc.contributor.author | Basu, Sandip | |
dc.contributor.author | Srinivas, S. | |
dc.contributor.author | Sankaran, S. | |
dc.contributor.author | Schuster, S. | |
dc.contributor.author | Alavi, A. | |
dc.date.accessioned | 2010-03-12T08:51:25Z | |
dc.date.available | 2010-03-12T08:51:25Z | |
dc.date.issued | 2008 | |
dc.format.extent | 6399 bytes | |
dc.format.mimetype | text/html | |
dc.identifier.uri | http://hdl.handle.net/123456789/2089 | |
dc.language.iso | en | en |
dc.subject | CT | en |
dc.subject | FDG | en |
dc.subject | lymphoma | en |
dc.subject | MRI | en |
dc.subject | non-Hodgkin’s lymphoma | en |
dc.subject | PET | en |
dc.title | Determination of whole-body metabolic burden as a quantitative measure of disease activity in lymphoma: A novel approach with fluorodeoxyglucose-PET | en |
dc.type | Article | en |